T. Rowe Price Associates’s Eastman Chemical EMN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $7.67M | Buy |
100,477
+11,456
| +13% | +$826K | ﹤0.01% | 1283 |
|
|
2025
Q4 | $5.68M | Sell |
89,021
-79,294
| -47% | -$4.89M | ﹤0.01% | 1351 |
|
|
2025
Q3 | $10.6M | Buy |
168,315
+1,437
| +0.9% | +$100K | ﹤0.01% | 1215 |
|
|
2025
Q2 | $12.5M | Buy |
166,878
+334
| +0.2% | +$26.2K | ﹤0.01% | 1071 |
|
|
2025
Q1 | $14.7M | Buy |
166,544
+1,468
| +0.9% | +$139K | ﹤0.01% | 1029 |
|
|
2024
Q4 | $15.1M | Sell |
165,076
-26
| -0% | -$2.67K | ﹤0.01% | 1049 |
|
|
2024
Q3 | $18.5M | Buy |
165,102
+2,659
| +2% | +$266K | ﹤0.01% | 1010 |
|
|
2024
Q2 | $15.9M | Buy |
162,443
+2,969
| +2% | +$295K | ﹤0.01% | 1014 |
|
|
2024
Q1 | $16M | Buy |
159,474
+750
| +0.5% | +$66K | ﹤0.01% | 1028 |
|
|
2023
Q4 | $14.3M | Sell |
158,724
-1
| -0% | -$80 | ﹤0.01% | 1028 |
|
|
2023
Q3 | $12.2M | Buy |
158,725
+372
| +0.2% | +$30.9K | ﹤0.01% | 1033 |
|
|
2023
Q2 | $13.3M | Sell |
158,353
-713,735
| -82% | -$58M | ﹤0.01% | 1030 |
|
|
2023
Q1 | $73.6M | Buy |
872,088
+713,832
| +451% | +$61.3M | 0.01% | 583 |
|
|
2022
Q4 | $12.9M | Sell |
158,256
-7,645
| -5% | -$616K | ﹤0.01% | 1012 |
|
|
2022
Q3 | $11.8M | Buy |
165,901
+1
| +0% | +$90 | ﹤0.01% | 1037 |
|
|
2022
Q2 | $14.9M | Sell |
165,900
-17,738
| -10% | -$1.84M | ﹤0.01% | 1242 |
|
|
2022
Q1 | $20.6M | Sell |
183,638
-16,731
| -8% | -$1.96M | ﹤0.01% | 1226 |
|
|
2021
Q4 | $24.2M | Sell |
200,369
-10,294
| -5% | -$1.14M | ﹤0.01% | 1237 |
|
|
2021
Q3 | $21.2M | Sell |
210,663
-1,212,674
| -85% | -$134M | ﹤0.01% | 1280 |
|
|
2021
Q2 | $166M | Buy |
1,423,337
+1,209,167
| +565% | +$145M | 0.02% | 618 |
|
|
2021
Q1 | $23.6M | Sell |
214,170
-18,150
| -8% | -$1.97M | ﹤0.01% | 1238 |
|
|
2020
Q4 | $23.3M | Sell |
232,320
-10,759
| -4% | -$998K | ﹤0.01% | 1186 |
|
|
2020
Q3 | $19M | Sell |
243,079
-8,581
| -3% | -$647K | ﹤0.01% | 1169 |
|
|
2020
Q2 | $17.5M | Sell |
251,660
-19,809
| -7% | -$1.25M | ﹤0.01% | 1177 |
|
|
2020
Q1 | $12.6M | Sell |
271,469
-3,005,553
| -92% | -$193M | ﹤0.01% | 1189 |
|
|
2019
Q4 | $260M | Buy |
3,277,022
+3,028,240
| +1,217% | +$233M | 0.03% | 428 |
|
|
2019
Q3 | $18.4M | Sell |
248,782
-6,911
| -3% | -$496K | ﹤0.01% | 1180 |
|
|
2019
Q2 | $19.9M | Buy |
255,693
+151
| +0.1% | +$11.5K | ﹤0.01% | 1178 |
|
|
2019
Q1 | $19.4M | Buy |
255,542
+8,240
| +3% | +$655K | ﹤0.01% | 1177 |
|
|
2018
Q4 | $18.1M | Buy |
247,302
+1,120
| +0.5% | +$89.3K | ﹤0.01% | 1177 |
|
|
2018
Q3 | $23.6M | Buy |
246,182
+138
| +0.1% | +$13.7K | ﹤0.01% | 1168 |
|
|
2018
Q2 | $24.6M | Buy |
246,044
+80
| +0% | +$8.45K | ﹤0.01% | 1135 |
|
|
2018
Q1 | $26M | Sell |
245,964
-1,060
| -0.4% | -$107K | ﹤0.01% | 1095 |
|
|
2017
Q4 | $22.9M | Sell |
247,024
-1,388,564
| -85% | -$126M | ﹤0.01% | 1143 |
|
|
2017
Q3 | $148M | Buy |
1,635,588
+1,364,154
| +503% | +$116M | 0.03% | 511 |
|
|
2017
Q2 | $22.8M | Buy |
271,434
+1,522
| +0.6% | +$123K | ﹤0.01% | 1122 |
|
|
2017
Q1 | $21.8M | Sell |
269,912
-5,670
| -2% | -$446K | ﹤0.01% | 1123 |
|
|
2016
Q4 | $20.7M | Buy |
275,582
+80
| +0% | +$5.78K | ﹤0.01% | 1133 |
|
|
2016
Q3 | $18.6M | Buy |
275,502
+3,423
| +1% | +$230K | ﹤0.01% | 1158 |
|
|
2016
Q2 | $18.5M | Sell |
272,079
-1,658
| -0.6% | -$122K | ﹤0.01% | 1127 |
|
|
2016
Q1 | $19.8M | Buy |
273,737
+17,091
| +7% | +$1.12M | ﹤0.01% | 1080 |
|
|
2015
Q4 | $17.3M | Sell |
256,646
-18,100
| -7% | -$1.27M | ﹤0.01% | 1130 |
|
|
2015
Q3 | $17.8M | Buy |
274,746
+15,400
| +6% | +$1.14M | ﹤0.01% | 1131 |
|
|
2015
Q2 | $21.2M | Buy |
259,346
+1,532
| +0.6% | +$118K | ﹤0.01% | 1123 |
|
|
2015
Q1 | $17.9M | Buy |
257,814
+1,800
| +0.7% | +$130K | ﹤0.01% | 1171 |
|
|
2014
Q4 | $19.4M | Buy |
256,014
+14,100
| +6% | +$1.11M | ﹤0.01% | 1120 |
|
|
2014
Q3 | $19.6M | Buy |
241,914
+5,200
| +2% | +$434K | ﹤0.01% | 1124 |
|
|
2014
Q2 | $20.7M | Sell |
236,714
-100
| -0% | -$8.69K | ﹤0.01% | 1111 |
|
|
2014
Q1 | $20.4M | Buy |
236,814
+4,600
| +2% | +$377K | ﹤0.01% | 1100 |
|
|
2013
Q4 | $18.7M | Sell |
232,214
-3,890
| -2% | -$302K | ﹤0.01% | 1110 |
|
|
2013
Q3 | $18.4M | Sell |
236,104
-2,110
| -0.9% | -$163K | ﹤0.01% | 1106 |
|
|
2013
Q2 | $16.7M | Buy |
+238,214
| New | +$16.6M | ﹤0.01% | 1117 |
|
Other funds holding EMN
VPM
VCM
T. Rowe Price Associates's EMN Position: Q1 2026 in Review
T. Rowe Price Associates increased its Eastman Chemical (EMN) stake by 13% in Q1 2026, buying an estimated $826K and bringing the position to 100,477 shares worth $7.67M. The position accounts for ﹤0.01% of the portfolio, ranked #1283.
T. Rowe Price Associates first reported a position in EMN in Q2 2013 and has held it in 52 quarters since. The position peaked at $260M in Q4 2019. 634 funds tracked by Wall St. Rank hold EMN as of Q1 2026.
- T. Rowe Price Associates held 100,477 shares of Eastman Chemical worth $7.67M as of Q1 2026.
- T. Rowe Price Associates bought 11,456 Eastman Chemical shares in Q1 2026, an estimated $826K.
- Eastman Chemical made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #1283 holding.
- T. Rowe Price Associates first reported a position in Eastman Chemical in Q2 2013 and has held it in 52 quarters since.
- T. Rowe Price Associates's Eastman Chemical position peaked at $260M in Q4 2019.
- 634 funds tracked by Wall St. Rank held Eastman Chemical as of Q1 2026.
Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.